Skip to content

Prevention of Neurosurgical Wound Infections

Pilot Project: Prevention of Neurosurgical Wound Infections

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00915967
Acronym
POWI
Enrollment
214
Registered
2009-06-08
Start date
2009-05-13
Completion date
2014-12-19
Last updated
2019-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical Wound Infections

Keywords

Infection, Vancomycin, Neurosurgery, Stimulator, Pump, Deep Brain Stimulation, Intrathecal Pump

Brief summary

The goal of this study is to determine whether injecting the antibiotic vancomycin directly into surgical wounds can decrease the rate of infection following implantation of neurosurgical devices.

Interventions

DRUGVancomycin

Subjects randomized to the vancomycin group will receive an injection (up to 10 mL) of 5 mg/mL vancomycin administered directly into the wound with a blunt needle following watertight fascial closure.

Subjects randomized to the saline group will receive an injection (up to 10 mL) of saline solution directly into the wound following watertight fascial closure.

Sponsors

Oregon Health and Science University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* deep brain stimulators (DBS) * spinal cord stimulators (SCS) * motor cortex stimulators (MCS) * vagus nerve stimulators (VNS) * peripheral nerve stimulators (PNS)

Exclusion criteria

* allergies to vancomycin * immunocompromise or taking immunosuppressant drugs * currently taking aminoglycoside antibiotics, such as amikacin, gentamicin, neomycin, streptomycin or tobramycin * diagnosed renal failure * currently undergoing chemotherapy * pregnancy * non-english speakers * unable to return for follow-up, or unable to be contacted by telephone

Design outcomes

Primary

MeasureTime frameDescription
Incidence of Infection That Requires Removal of the Neurosurgical DeviceSix months post-operationThe primary outcome was infection that required removal of the implanted device within 6 months of surgery. At our institution all patients with evidence of hardware infection have the entire stimulation/pump system removed. Subjects were either seen in clinic or reached by telephone more than 6 months after surgery and assessed for whether they had had infection requiring hardware removal or any superficial infection requiring additional post-operative antibiotics.

Countries

United States

Participant flow

Recruitment details

214 subjects signed consent. 198 subjects were enrolled.

Participants by arm

ArmCount
Vancomycin
Subjects in the experimental group will receive Vancomycin injected directly into the wound pocket. Vancomycin: Subjects randomized to the vancomycin group will receive an injection (up to 10 mL) of 5 mg/mL vancomycin administered directly into the wound with a blunt needle following watertight fascial closure.
98
Saline
Subjects in the saline group will receive a Saline injection directly into the wound pocket. Placebo (Saline Solution): Subjects randomized to the saline group will receive an injection (up to 10 mL) of saline solution directly into the wound following watertight fascial closure.
100
Total198

Baseline characteristics

CharacteristicSalineTotalVancomycin
Age, Continuous64 Years63.5 Years63 Years
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
100 participants198 participants98 participants
Sex: Female, Male
Female
37 Participants77 Participants40 Participants
Sex: Female, Male
Male
63 Participants121 Participants58 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 980 / 100
other
Total, other adverse events
2 / 985 / 100
serious
Total, serious adverse events
0 / 980 / 100

Outcome results

Primary

Incidence of Infection That Requires Removal of the Neurosurgical Device

The primary outcome was infection that required removal of the implanted device within 6 months of surgery. At our institution all patients with evidence of hardware infection have the entire stimulation/pump system removed. Subjects were either seen in clinic or reached by telephone more than 6 months after surgery and assessed for whether they had had infection requiring hardware removal or any superficial infection requiring additional post-operative antibiotics.

Time frame: Six months post-operation

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
VancomycinIncidence of Infection That Requires Removal of the Neurosurgical Device97 Participants
SalineIncidence of Infection That Requires Removal of the Neurosurgical Device98 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026